These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9355922)

  • 1. Aprotinin: topical or systemic delivery in left ventricular assist device implantation.
    Hariawala MD
    Circulation; 1997 Oct; 96(8):2736-7. PubMed ID: 9355922
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery].
    Yasim A; Aşik R; Atahan E
    Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-volume hemofiltration as rescue therapy for refractory shock after inadvertent rapid aprotinin administration.
    Lango R; Kowalik MM; Klajbor K; Pawlaczyk R; Musiał-Swiatkiewicz V; Rogowski J
    J Cardiothorac Vasc Anesth; 2009 Aug; 23(4):526-8. PubMed ID: 18835530
    [No Abstract]   [Full Text] [Related]  

  • 4. Is there a surgical role for topical aprotinin?
    Sethi M; Anton JM; Collard CD
    Anesthesiology; 2008 May; 108(5):967. PubMed ID: 18431140
    [No Abstract]   [Full Text] [Related]  

  • 5. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
    Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
    Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of aprotinin and a heparin-bonded cardiopulmonary bypass system for aortic aneurysm repair.
    Gallagher JM; Brown ME; Gasior TA
    J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):728-30. PubMed ID: 8664469
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary on: First American experience with the Terumo DuraHeart ventricular assist system.
    Griffith K
    Perfusion; 2009 Mar; 24(2):91-2. PubMed ID: 19654149
    [No Abstract]   [Full Text] [Related]  

  • 8. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
    J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placement of long-term implantable ventricular assist devices without the use of cardiopulmonary bypass.
    Sun BC; Firstenberg MS; Louis LB; Panza A; Crestanello JA; Sirak J; Sai-Sudhakar CB
    J Heart Lung Transplant; 2008 Jul; 27(7):718-21. PubMed ID: 18582799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro: Aprotinin should be used in coronary artery bypass graft surgery with cardiopulmonary bypass.
    Hill SE
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):298-301. PubMed ID: 17418753
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
    Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
    Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aprotinin (trasylol) on the inflammatory and thrombotic complications of conventional cardiopulmonary bypass surgery.
    Landis RC; Asimakopoulos G; Poullis M; Thompson R; Nourshargh S; Haskard DO; Taylor KM
    Heart Surg Forum; 2001; 4 Suppl 1():S35-9. PubMed ID: 11178306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprotinin: antifibrinolytic and anti-inflammatory mechanisms of action in cardiac surgery with cardiopulmonary bypass.
    Donahue MA; Price PM
    Dynamics; 2002; 13(3):16-23. PubMed ID: 12640841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low doses of aprotinin in reducing blood loss and allogenic transfusions in operation under conditions of extracorporeal circulation with using cell saver].
    Naumenko SE; Naumenko KS; Pokrovskiĭ MG
    Vestn Khir Im I I Grek; 2005; 164(6):69-73. PubMed ID: 16792320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-centre trial of aprotinin highlights increased safety with higher dose.
    Cardiovasc J S Afr; 2002; 13(2):80. PubMed ID: 12166359
    [No Abstract]   [Full Text] [Related]  

  • 16. Con: Aprotinin should not be used in cardiac surgery with cardiopulmonary bypass.
    Augoustides JG
    J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):302-4. PubMed ID: 17418754
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain natriuretic peptide in cardiac surgery--influence of aprotinin.
    Bail DH; Ziemer G
    Int J Cardiol; 2009 Aug; 136(2):227-8. PubMed ID: 18625528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aprotinin versus tranexamic acid: the controversy continues.
    Levy JH
    Transfusion; 2006 Mar; 46(3):319-20. PubMed ID: 16533270
    [No Abstract]   [Full Text] [Related]  

  • 19. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aprotinin.
    Alston TA
    Int Anesthesiol Clin; 2004; 42(4):81-91. PubMed ID: 15577702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.